Thus, albeit a comparable elevation of hepatic CYP2E1 content and function, gp78−/−-mice exhibited an above normal insulin-signaling response and were spared the lipogenic scenario that progressively leads to NAFLD/NASH in CHIP−/−-mice [29,34]. This evidence concerns the gene CYP2E1 and metabolic dysfunction-associated steatotic liver disease.